hotspot -WSS

hotspot

author：knowledge 2025-09-29 21:27:17 - browse：437

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Why we need to separate burnout from moral injury in health care

WSS

Bernie brings in new pharma CEOs to talk drug prices

The strategy behind pharma's lawsuits over drug pricing reform

Padmanee Sharma of MD Anderson at center of lawsuit over credit

A single Democrat is willing to weaken Medicare negotiation power

A single Democrat is willing to weaken Medicare negotiation power

Do masks work? RCTs can't tell us

leisure time

hotspot

hotspot

Drug repurposing or repositioning? The language matters

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

DIEP, the 'gold standard' of breast reconstruction, is under threat

Cano Health’s bankruptcy is a warning for Medicare Advantage

Medical leaders decry Supreme Court decision on affirmative action

Medicare Advantage plans can’t deny care with AI, CMS warns

Alkermes shareholders re

Why are elite athletes different? Take a look at their microbes

As demand for Covid shots wanes, Moderna seeks its next success

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Wikipedia

New guidelines on severe brain injury complicate already difficult decisions

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Cano Health’s bankruptcy is a warning for Medicare Advantage

The battle over the Brookhaven Landfill on Long Island

With FDA staff opposed to Sarepta therapy, top official intervened

Donald Trump's relentless attacks on special counsel Jack Smith

hotspot

explore

focus

focus